CGEN Q4 2021 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena

CGENCompugen Ltd.

$202M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$9M

Net Income

-$9M

EPS (Diluted)

$-0.10

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$132M

Total Liabilities

$25M

Stockholders' Equity

$107M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$2M	-100.0%
Gross Profit	$0	$2M	-100.0%
Operating Income	-$9M	-$9M	+3.4%
Net Income	-$9M	-$9M	-1.0%